Integrating randomized controlled trials and non-randomized studies of interventions to assess the effect of rare events: a Bayesian re-analysis of two meta-analyses

被引:2
作者
Zhou, Yun [1 ,2 ,3 ,4 ]
Yao, Minghong [1 ,2 ,3 ,5 ,6 ]
Mei, Fan [1 ,2 ,3 ,5 ,6 ]
Ma, Yu [1 ,2 ,3 ,5 ,6 ]
Huan, Jiayidaer [1 ,2 ,3 ,5 ,6 ]
Zou, Kang [1 ,2 ,3 ,5 ,6 ]
Li, Ling [1 ,2 ,3 ,5 ,6 ]
Sun, Xin [1 ,2 ,3 ,5 ,6 ,7 ,8 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, 37 Guo Xue Xiang, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Ctr & MAGIC China Ctr, Cochrane China, 37 Guo Xue Xiang, Chengdu, Sichuan, Peoples R China
[4] Sichuan Univ, West China Hosp, President & Deans Off, Chengdu, Peoples R China
[5] Sichuan Univ, West China Hosp, NMPA Key Lab Real World Data Res & Evaluat Hainan, Chengdu, Peoples R China
[6] Sichuan Univ, West China Hosp, Sichuan Ctr Technol Innovat Real World Data, Chengdu, Peoples R China
[7] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Biostat, Chengdu, Peoples R China
[8] Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
Meta-analysis; Rare events; Non-randomized studies of interventions; Risk of bias; SYSTEMATIC REVIEWS; QUALITY;
D O I
10.1186/s12874-024-02347-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundThere is a growing trend to include non-randomised studies of interventions (NRSIs) in rare events meta-analyses of randomised controlled trials (RCTs) to complement the evidence from the latter. An important consideration when combining RCTs and NRSIs is how to address potential bias and down-weighting of NRSIs in the pooled estimates. The aim of this study is to explore the use of a power prior approach in a Bayesian framework for integrating RCTs and NRSIs to assess the effect of rare events.MethodsWe proposed a method of specifying the down-weighting factor based on judgments of the relative magnitude (no information, and low, moderate, serious and critical risk of bias) of the overall risk of bias for each NRSI using the ROBINS-I tool. The methods were illustrated using two meta-analyses, with particular interest in the risk of diabetic ketoacidosis (DKA) in patients using sodium/glucose cotransporter-2 (SGLT-2) inhibitors compared with active comparators, and the association between low-dose methotrexate exposure and melanoma.ResultsNo significant results were observed for these two analyses when the data from RCTs only were pooled (risk of DKA: OR = 0.82, 95% confidence interval (CI): 0.25-2.69; risk of melanoma: OR = 1.94, 95%CI: 0.72-5.27). When RCTs and NRSIs were directly combined without distinction in the same meta-analysis, both meta-analyses showed significant results (risk of DKA: OR = 1.50, 95%CI: 1.11-2.03; risk of melanoma: OR = 1.16, 95%CI: 1.08-1.24). Using Bayesian analysis to account for NRSI bias, there was a 90% probability of an increased risk of DKA in users receiving SGLT-2 inhibitors and an 91% probability of an increased risk of melanoma in patients using low-dose methotrexate.ConclusionsOur study showed that including NRSIs in a meta-analysis of RCTs for rare events could increase the certainty and comprehensiveness of the evidence. The estimates obtained from NRSIs are generally considered to be biased, and the possible influence of NRSIs on the certainty of the combined evidence needs to be carefully investigated.
引用
收藏
页数:13
相关论文
共 61 条
[31]   Sodium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials [J].
Liu, Jiali ;
Li, Ling ;
Li, Sheyu ;
Wang, Yuning ;
Qin, Xuan ;
Deng, Ke ;
Liu, Yanmei ;
Zou, Kang ;
Sun, Xin .
DIABETES OBESITY & METABOLISM, 2020, 22 (09) :1619-1627
[32]   The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study [J].
McGurnaghan, Stuart J. ;
Brierley, Liam ;
Caparrotta, Thomas M. ;
McKeigue, Paul M. ;
Blackbourn, Luke A. K. ;
Wild, Sarah H. ;
Leese, Graham P. ;
McCrimmon, Rory J. ;
McKnight, John A. ;
Pearson, Ewan R. ;
Petrie, John R. ;
Sattar, Naveed ;
Colhoun, Helen M. .
DIABETOLOGIA, 2019, 62 (04) :621-632
[33]  
Moola S, 2017, JOANN BRIGGS I REV M
[34]   Standards and guidelines for observational studies: quality is in the eye of the beholder [J].
Morton, Sally C. ;
Costlow, Monica R. ;
Graff, Jennifer S. ;
Dubois, Robert W. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2016, 71 :3-10
[35]   Including nonrandomized studies of interventions in systematic reviews: principles and practicalities [J].
Munn, Zachary ;
Barker, Timothy Hugh ;
Aromataris, Edoardo ;
Klugar, Miloslav ;
Sears, Kim .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2022, 152 :314-315
[36]  
Myles J.P., 2004, Bayesian Approaches to Clinical Trials and Health-Care Evaluation
[37]   Domperidone increases harmful cardiac events in Parkinson's disease: A Bayesian re-analysis of an observational study [J].
Nakhle, Gisele ;
Brophy, James M. ;
Renoux, Christel ;
Khairy, Paul ;
Belisle, Patrick ;
LeLorier, Jacques .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2021, 140 :93-100
[38]   Critical appraisal of nonrandomized studies-A review of recommended and commonly used tools [J].
Quigley, Joan M. ;
Thompson, Juliette C. ;
Halfpenny, Nicholas J. ;
Scott, David A. .
JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2019, 25 (01) :44-52
[39]   Treating Individuals 1 - External validity of randomised controlled trials: "To whom do the results of this trial apply?"' [J].
Rothwell, PM .
LANCET, 2005, 365 (9453) :82-93
[40]   Inclusion of nonrandomized studies of interventions in systematic reviews of interventions: updated guidance from the Agency for Health Care Research and Quality Effective Health Care program [J].
Saldanha, Ian J. ;
Adam, Gaelen P. ;
Banez, Lionel L. ;
Bass, Eric B. ;
Berliner, Elise ;
Devine, Beth ;
Hammarlund, Noah ;
Jain, Anjali ;
Norris, Susan L. ;
Skelly, Andrea C. ;
Vander Ley, Kelly ;
Wang, Zhen ;
Wilt, Timothy J. ;
Viswanathan, Meera .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2022, 152 :300-306